USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ALPHA-BETA TECHNOLOGY, INC.
Address:
Worcester, MA 01605
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $346,875.00 4

Award List:

MACROPHAGE-ACTIVATING ADJUVANTS FOR HIV VACCINES

Award Year / Program / Phase:
1989 / SBIR / Phase I
Award Amount:
$48,100.00
Agency:
HHS
Principal Investigator:
Abstract:
The yeast-cell-wall component, beta-glucan, is a potent activator of both humoral and cellular systems of host defense. it is now known that one of the mechanisms controlling these responses is activation of mononuclear and polymorphonuclear phagocytes via specific cell-surface beta-glucan… More

Functionalized Carbohydrate Cholesterol Lowering Agent

Award Year / Program / Phase:
1995 / SBIR / Phase I
Award Amount:
$99,382.00
Agency:
HHS
Principal Investigator:
Gary Ostroff
Abstract:
Hypercholesterolemia constitutes a major risk factor for cardiovascular disease, the leading causeAmerica. Among the lipid-lowering therapeutics, non-systemics are frequently preferred over systemicassociated with fewer potential side effects. However, even the present non-systemics have… More

PGG-GLUCAN FOR THE TREATMENT OF PERIODONTAL DISEASE

Award Year / Program / Phase:
1996 / SBIR / Phase I
Award Amount:
$99,974.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

BETA 1,3 GLUCAN MICROFIBRIL ASSEMBLY--ANTIFUNGAL TARGET

Award Year / Program / Phase:
1998 / SBIR / Phase I
Award Amount:
$99,419.00
Agency:
HHS
Principal Investigator:
Galbraith, William
Abstract:
N/a